US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
EXMAR NV (0EEV) 銘柄情報

EXMAR NV (0EEV)

6.26

0.00

(0.00%)

終了 6月17日 12:30AM

EXMAR NV (0EEV) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

6.26

( - )

買値

6.26

売値

6.26

出来高

0.00

0.00 日の範囲 0.00

6.26 52 週間の範囲 6.26

時価総額

前日終値

6.26

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,351 €

発行済株式数

79,516,197

配当利回り

0.59

PER

11.62

1 株当たり利益 (EPS)

1.15

歳入

248.14M

純利益

74.34M

Exmar NV engages in the provision of shipping and floating infrastructure solutions worldwide. The company operates through Shipping, Infrastructure, and Supporting Services segments. It transports liquefied gas products, such as liquid natural gas, liquid petroleum gas, butane, propane, anhydrous a... Exmar NV engages in the provision of shipping and floating infrastructure solutions worldwide. The company operates through Shipping, Infrastructure, and Supporting Services segments. It transports liquefied gas products, such as liquid natural gas, liquid petroleum gas, butane, propane, anhydrous ammonia, and petrochemical gases. The company also offers floating infrastructure solutions to the oil and gas industries by making use of its asset portfolio, and through developing new assets for near-shore and offshore production, processing, storage or other ancillary services. In addition, it provides ship management, technical and crewing, consultancy and engineering, manufacturing, travel agency, yachting, and investment portfolio services, as well as manufactures ropes for marine, industrial, and offshore applications. The company serves fertilizer, clean energy fuel, and petrochemical industries. Exmar NV was founded in 1829 and is headquartered in Antwerp, Belgium. The company operates as a subsidiary of Saverex NV. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.exmar.com

本社

Antwerp, Belgium

設立

2026

EXMAR NV is listed in the sector of the ロンドン証券取引所 with ticker 0EEV. The last closing price for EXMAR NV was 6.26 €. Over the last year, EXMAR NV shares have traded in a share price range of 6.26 € to 6.26 €.

EXMAR NV currently has 79,516,197 shares in issue. The market capitalisation of EXMAR NV is 497.77 € million. EXMAR NV has a price to earnings ratio (PE ratio) of 11.62.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	6.26	6.26	6.26	91	6.26	DE
52	0	0	6.26	6.26	6.26	211	6.26	DE
156	0	0	6.26	6.26	6.26	1872	6.26	DE
260	0	0	6.26	6.26	6.26	4718	6.26	DE

0EEV - Frequently Asked Questions (FAQ)

What is the current EXMAR NV share price?

The current share price of EXMAR NV is 6.26 €

How many EXMAR NV shares are in issue?

EXMAR NV has 79,516,197 shares in issue

What is the market cap of EXMAR NV?

The market capitalisation of EXMAR NV is EUR 497.77M

What is the 1 year trading range for EXMAR NV share price?

EXMAR NV has traded in the range of 6.26 € to 6.26 € during the past year

What is the PE ratio of EXMAR NV?

The price to earnings ratio of EXMAR NV is 11.62

What is the cash to sales ratio of EXMAR NV?

The cash to sales ratio of EXMAR NV is 4.27

What is the registered address of EXMAR NV?

The registered address for EXMAR NV is De Gerlachekaai 20, Antwerp, Antwerp, 2000

What is the EXMAR NV website address?

The website address for EXMAR NV is www.exmar.com

Termite7

Termite7 3分前

Soon isn't the word......

US Market News

US Market News 10分前

Guardian Metal Resources PLC Announces Acquisition of Lincoln Estates & Water RightsJune 17, 2026 2:00 AM
ACCESS NewswireLONDON, UK / ACCESS Newswire / June 17, 2026 / Guardian Metal Res

DutchInvest

DutchInvest 14分前

Summary- LWLG has developed EO polymer, BEOL and SOH modulator device technology- EO polymer material and encapsulation achieved Telcordia reliability performance at thin filmand device level. Additional reliability studies underway for various reference devices- 200 and 400Gb/s devices designed and

tootalljones

tootalljones 19分前

I see that I have 161 followers. As we all know here on this erudite board of elderlies, I deserve no followers whatsoever. ......but I do need some new teeth. yep, my dentist told me that I need new choppers. .......so I want this buyout for 16 bucks to come through, and then I can get the chopp

MasterBlastr

MasterBlastr 21分前

Only thing I'm worried about is what do I do when my wallet is so fat I can't close it. Oh wait I have an idea.

https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcScVGQpebCFkwMdergI3prtoa19XfhB4lvLaeyONi53rw&s=10

US Market News

US Market News 25分前

Nextpower Announces Expansion of Solar Product Portfolio for International MarketJune 17, 2026 2:00 AM
Business Wire New two-in-portrait (2P) tracker system and innovative integrated foundation solution address comprehensive range of site and land-use requireme

Ammarmalhas

Ammarmalhas 33分前

At 67 and invested for 10+ years and still holding I must think of; Had I invested this money in an AI share this year I would have tripled my money!! Are we correct in holding on!? What are we really waiting for!? I may be losing faith!

ORCA

I SAW THE NEWS ON $VPLM AFTER MARKET.
I CHECKED OUT THE FIRM THEY BROUGHT IN.
THEY ARE BRINGING IN THE BIG GUNS.AGAINST READ BOLD.I AM INCREASING MY TARGETS AFTER THIS NEWS.
FROM .025 HIGH TO .15 WITHIN 2 YEARS.THE STOCK IS SHIFTING TO A POSITIVE OUT LOOK.IMO.
LAST COU

Steady_T

Steady_T 43分前

And yet your entire post is a personal attack. How strange.Clearly not as you wouldn't understand a shady OTC biotech penny stock with little chance of success. You clearly have too much money tied up in this and seem to only respond with personal attacks. Not pretty, hope it's not your retirement m

MineInvestor01

MineInvestor01 46分前

The June 17 announcement was encouraging to read. DTREF’s magnetic and radiometric surveys in Music Valley confirm it is clearly worthwhile to do more exploration. The elevated thorium signatures and the monazite and xenotime mineralization are positives. More needs to be done, of course. That is al

ducci1

ducci1 48分前

Pivot Calcs: SPX Pivot 7527---R1 7547---S1 7491---SPY Pivot 751---R1 753---S1 748----ES Pivot 7606---R1 7634---S1 7577----VIX Pivot 16.20---R1 16,64---S1 15.97---15 min Bull//Bear R/Line 17.42!------!!LOL!!

MartinLutherKing

MartinLutherKing 1時間前

SEii Is Going Nuclear ☢️ With News.. Stay Tuned for life changing news$$$$

Achilles deFlandres

Achilles deFlandres 1時間前

IMHO, one major event explicitly impacting the timeline of f2 relisting; IT IS NOT IN THE TOP TEN PRIORITIES, MAYBE NOT TOP 100. And, events all take precedence.

nshi2

nshi2 1時間前

Translating the OLED Playbook to EOP
Reliability Challenge Modern OLED Solution Electro-Optic Polymer Equivalent
Moisture/Oxygen Ingress (Damp Heat) Dyadic Thin-Film Encapsulation (TFE / ALD) Atomic layer deposition (ALD) directly over the EOP slot
waveguide; passes 85/85 dam

CelestialSage6

CelestialSage6 1時間前

It is unfortunate news that Halozyme eventually gave up the mdase patent.

https://www.thebionews.net/news/articleView.html?idxno=25562

MartinLutherKing

MartinLutherKing 1時間前

Keep lying to yourself, we all know your looking for em cheapies.. The pedlar short flippers are out of ammo.. Your out of luck, got to slap the ask

Watts Watt

Watts Watt 1時間前

Smart investors would take advantage of sharp price drops and scoop up cheap shares manically. To get Jack, you got to be nimble...nary tremble. Frick stay?

shajandr

shajandr 1時間前

IMO, Australia and similarly situated oil consumers should treat this 60-day opening as temporary and they ought to buy and ship as much oil as they can gett their hands on in the next 60 days. These types of oil importers should be willing to pay top Dollar to obtain as much oil as they can handle

Stockman1010101

Stockman1010101 1時間前

FNMA & FMCC Stock prices targets:
- 1st Target: $9, met 2026
- 2nd Target: $12, met 2026
- 3rd Target: $16, met 2026
- 4th Target: $20, met 2026
-5th Target: $30, met 2027
- 6th Target: $50, met 2027
- 7th Target: $70, met 2027
- 8th Target: $1

Steady_T

Steady_T 1時間前

I wondered when you would resort to personal attacks.

Your arguments are weak and do not stand up to scrutiny.
So time to switch to plan B, attack the poster.

Steady_T

Steady_T 1時間前

No I don't and neither do you. That is not the issue. NICE may not decide that the cost that NWBO is willing to accept is worth the result.

That is an unknown. If NICE looks at the data and decides that the survival benefit is not worth the cost then the treatment will not be reimbur

Unlimit Group AS

Bond 4000% bis 24.01.2031

NBI Sustainable Global E...

First Trust IPOX Europe ...

BNP Paribas Easy MSCI EM...

Switchback Energy Acquis...

iPath Series B Bloomberg...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。